IMNM
Price
$14.10
Change
-$0.15 (-1.05%)
Updated
Oct 14 closing price
Capitalization
1.22B
33 days until earnings call
Intraday Buy/Sell Signals
SLN
Price
$5.84
Change
+$0.34 (+6.18%)
Updated
Oct 14 closing price
Capitalization
212.55M
34 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

IMNM vs SLN

Header iconIMNM vs SLN Comparison
Open Charts IMNM vs SLNBanner chart's image
Immunome
Price$14.10
Change-$0.15 (-1.05%)
Volume$674.55K
Capitalization1.22B
Silence Therapeutics
Price$5.84
Change+$0.34 (+6.18%)
Volume$194.04K
Capitalization212.55M
IMNM vs SLN Comparison Chart in %
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. SLN commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and SLN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (IMNM: $14.10 vs. SLN: $5.84)
Brand notoriety: IMNM and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 55% vs. SLN: 242%
Market capitalization -- IMNM: $1.22B vs. SLN: $212.55M
IMNM [@Biotechnology] is valued at $1.22B. SLN’s [@Biotechnology] market capitalization is $212.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, IMNM is a better buy in the long-term than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 6 TA indicator(s) are bullish while SLN’s TA Score has 5 bullish TA indicator(s).

  • IMNM’s TA Score: 6 bullish, 4 bearish.
  • SLN’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than SLN.

Price Growth

IMNM (@Biotechnology) experienced а +2.03% price change this week, while SLN (@Biotechnology) price change was +13.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.76%. For the same industry, the average monthly price growth was +13.99%, and the average quarterly price growth was +268.92%.

Reported Earning Dates

IMNM is expected to report earnings on Nov 17, 2025.

SLN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+0.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($1.23B) has a higher market cap than SLN($213M). IMNM YTD gains are higher at: 32.768 vs. SLN (-15.116). SLN has higher annual earnings (EBITDA): -84.82M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. SLN (114M). SLN has less debt than IMNM: SLN (0) vs IMNM (4.14M). SLN has higher revenues than IMNM: SLN (27.2M) vs IMNM (12.6M).
IMNMSLNIMNM / SLN
Capitalization1.23B213M575%
EBITDA-187.92M-84.82M222%
Gain YTD32.768-15.116-217%
P/E RatioN/AN/A-
Revenue12.6M27.2M46%
Total Cash268M114M235%
Total Debt4.14M0-
TECHNICAL ANALYSIS
Technical Analysis
IMNMSLN
RSI
ODDS (%)
Bearish Trend 8 days ago
86%
Bullish Trend 13 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 8 days ago
90%
Bullish Trend 8 days ago
82%
Momentum
ODDS (%)
Bullish Trend 8 days ago
90%
Bullish Trend 8 days ago
82%
MACD
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 8 days ago
74%
TrendWeek
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 8 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 8 days ago
84%
Bearish Trend 8 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
82%
Bullish Trend 17 days ago
88%
Declines
ODDS (%)
Bearish Trend 29 days ago
87%
Bearish Trend 15 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
81%
Aroon
ODDS (%)
Bullish Trend 8 days ago
82%
Bearish Trend 8 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAYZF32.08N/A
N/A
Bayer A.G.
EDESY19.15N/A
N/A
Elders Ltd
RWCRF0.38N/A
N/A
RIWI Corp.
XBOTF0.44-0.01
-2.22%
REALBOTIX CORP
XYIGY20.99-1.25
-5.62%
Xinyi Glass Holdings Ltd.

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with IDYA. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-1.05%
IDYA - IMNM
60%
Loosely correlated
+1.12%
SYRE - IMNM
55%
Loosely correlated
+11.02%
RLAY - IMNM
54%
Loosely correlated
-3.83%
IPSC - IMNM
54%
Loosely correlated
+1.78%
NRIX - IMNM
52%
Loosely correlated
-5.56%
More

SLN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLN has been loosely correlated with CLLS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SLN jumps, then CLLS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLN
1D Price
Change %
SLN100%
+6.18%
CLLS - SLN
43%
Loosely correlated
-5.66%
ANNX - SLN
35%
Loosely correlated
-0.17%
NGNE - SLN
33%
Loosely correlated
+5.00%
IMNM - SLN
33%
Poorly correlated
-1.05%
IDYA - SLN
33%
Poorly correlated
+1.12%
More